Evidence map›Paper›PMID 25022716›Full record

ReviewEuropean archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery2015

Impact of prophylactic central neck dissection on oncologic outcomes of papillary thyroid carcinoma: a review.

Elisabeth Mamelle, Isabelle Borget, Sophie Leboulleux, Haïtham Mirghani, Carlos Suárez, Phillip K Pellitteri, Ashok R Shaha, Marc Hamoir, K Thomas Robbins, Avi Khafif and 5 more

Open access · greenAbstract readReview
In one paragraph

Review in European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 39 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Effect of prophylactic central neck dissection on the surgical outcomes in papillary thyroid cancer: experience in a single center.European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery · 2020
    Article
  6. Article
  7. Article
  8. Article
  9. Pattern of nodal involvement in papillary thyroid cancer: a challenge of quantitative analysis.International journal of clinical and experimental pathology · 2015
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 10 institutions in 5 countries.

Elisabeth MamelleThyroid Surgery Unit, Department of Head and Neck Oncology, Institut Gustave Roussy, Paris-Sud University, Villejuif, France.
Isabelle Borget
Sophie Leboulleux
Haïtham Mirghani
Carlos Suárez
Phillip K Pellitteri
Ashok R Shaha
Marc Hamoir
K Thomas Robbins
Avi Khafif
Juan P Rodrigo
Carl E Silver
Alessandra Rinaldo
Alfio Ferlito
Dana M Hartl
Institut Gustave Roussy · FRUniversity of Udine · ITAssuta Medical Center · ILGuthrie Foundation · USHospital Universitario Central de Asturias · ESInstituto de Investigación Sanitaria del Principado de Asturias · ESMemorial Sloan Kettering Cancer Center · USMontefiore Medical Center · USSouthern Illinois University School of Medicine · USUniversité Paris-Sud · FR

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Nicholas D Socci · 1985 to 2026
$347.4M
NCI NIH HHS P30 CA008748
6 · The paper itself

Abstract

Prophylactic neck dissection (PND) for papillary thyroid carcinoma (PTC) is controversial. Our aim was to assess current levels of evidence (LE) according to the Oxford Centre for Evidence-based Medicine ( http://www.cebm.net/?O=1025 ) regarding the oncologic benefits of PND. Data were analyzed via MEDLINE keywords: PTC, differentiated thyroid carcinoma, PND, central lymph node metastases, central compartment, recurrence-free survival. There was conflicting evidence regarding the rate of reoperation for recurrence, with some studies showing a lower rate after PND with increased recurrence-free survival and a higher rate of undetectable pre- and post-ablation thyroglobulin levels (LE 4), whereas other studies did not show a difference (LE 4). Only one study (LE 4) showed improved disease-specific survival with PND. PND may improve recurrence-free survival, although this is supported by only a low LE. Current recommendations can only be based on low-level evidence.

Indexed as

CarcinomaCarcinoma, PapillaryNeoplasm Recurrence, LocalThyroid NeoplasmsHumansLymphatic MetastasisNeck DissectionOutcome Assessment, Health CareProphylactic Surgical ProceduresReoperationThyroid Cancer, PapillaryThyroidectomy

Identifiers

PMID25022716
PMCPMC4986511
OpenAlexW2027505699

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.